Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 6387810, 14 pages
https://doi.org/10.1155/2018/6387810
Review Article

High Vimentin Expression Predicts a Poor Prognosis and Progression in Colorectal Cancer: A Study with Meta-Analysis and TCGA Database

1Key Laboratory of Resources Biology and Biotechnology in Western China, Ministry of Education, College of Life Science, Northwest University, Xi’an 710069, China
2Institute of Preventive Genomic Medicine, Xi’an 710069, China
3The Fourth Military Medical University, Xi’an 710032, China

Correspondence should be addressed to Jin Yang; nc.ude.uwn@nijgnay

Received 18 January 2018; Revised 10 April 2018; Accepted 29 April 2018; Published 31 May 2018

Academic Editor: Lei Yao

Copyright © 2018 Le Du et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Fitzmaurice, H. Hamavid, D. Dicker, C. Allen, and M. Naghavi, “The Global Burden of Non-Hodgkin Lymphoma,” Clinical Lymphoma, Myeloma & Leukemia, vol. 15, p. S70, 2015. View at Publisher · View at Google Scholar
  2. H. He, L. Lei, E. Chen et al., “The screening of the functional microRNA binding site SNPs in sporadic colorectal cancer genes,” Cancer Biology & Therapy, vol. 18, no. 6, pp. 407–413, 2017. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Gurzu, C. Silveanu, A. Fetyko, V. Butiurca, Z. Kovacs, and I. Jung, “Systematic review of the old and new concepts in the epithelial-mesenchymal transition of colorectal cancer,” World Journal of Gastroenterology, vol. 22, no. 30, pp. 6764–6775, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. S. J. Serrano-Gomez, M. Maziveyi, and S. K. Alahari, “Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications,” Molecular Cancer, vol. 15, no. 1, article 18, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. J. P. Thiery and J. P. Sleeman, “Complex networks orchestrate epithelial-mesenchymal transitions,” Nature Reviews Molecular Cell Biology, vol. 7, no. 2, pp. 131–142, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. J. P. Their, “Epithelial-mesenchymal transitions in tumor progression,” Nature Reviews Cancer, vol. 2, no. 6, pp. 442–454, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Zeisberg and E. G. Neilson, “Biomarkers for epithelial-mesenchymal transitions,” The Journal of Clinical Investigation, vol. 119, no. 6, pp. 1429–1437, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Heerboth, G. Housman, M. Leary et al., “EMT and tumor metastasis,” linical and Translational Medicine, vol. 4, no. 1, article 6, 2015. View at Publisher · View at Google Scholar
  10. M. Sato, D. S. Shames, and Y. Hasegawa, “Emerging evidence of epithelial-to-mesenchymal transition in lung carcinogenesis,” Respirology, vol. 17, no. 7, pp. 1048–1059, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. H. E. Rashed, S. Hussein, H. Mosaad et al., “Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer,” Cancer Biomarkers, vol. 20, no. 1, pp. 107–122, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Toiyama, H. Yasuda, S. Saigusa et al., “Increased expression of slug and vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer,” Carcinogenesis, vol. 34, no. 11, pp. 2548–2557, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. J. L. Tan, Q. Chen, S. S. Qiao, Q. Y. Qin, Li. Jr Deng M. L. et al., “Expression and clinical significance of vimentin in colorectal adenocarcinoma,” Journal of Guangxi Medical University, pp. 829–831, 2016. View at Google Scholar
  14. C. Y. Ngan, H. Yamamoto, I. Seshimo et al., “Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer,” British Journal of Cancer, vol. 96, no. 6, pp. 986–992, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J.-A. Yun, S.-H. Kim, H. K. Hong et al., “Loss of E-cadherin expression is associated with a poor prognosis in stage III colorectal cancer,” Oncology (Switzerland), vol. 86, no. 5-6, pp. 318–328, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Moher, L. Shamseer, and M. Clarke, “Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement,” Systematic Reviews, vol. 4, no. 1, article 1, 2015. View at Publisher · View at Google Scholar
  17. A. Stang, “Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses,” European Journal of Epidemiology, vol. 25, no. 9, pp. 603–605, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Yang, B. Liu, B. Huang et al., “A functional copy number variation in the WWOX gene is associated with lung cancer risk in Chinese,” Human Molecular Genetics, vol. 22, no. 9, pp. 1886–1894, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. K. B. Parmar, V. Torri, and L. Stewart, “Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints,” Statistics in Medicine, vol. 17, no. 24, pp. 2815–2834, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. G. H. Guyatt, A. D. Oxman, R. Kunz et al., “GRADE guidelines: 7. Rating the quality of evidence—inconsistency,” Journal of Clinical Epidemiology, vol. 64, no. 12, pp. 1294–1302, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. P. Ioannidis, N. A. Patsopoulos, and E. Evangelou, “Uncertainty in heterogeneity estimates in meta-analyses,” British Medical Journal, vol. 335, no. 7626, pp. 914–916, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. C. B. Begg and M. Mazumdar, “Operating characteristics of a rank correlation test for publication bias,” Biometrics, vol. 50, no. 4, pp. 1088–1101, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Egger, G. D. Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” British Medical Journal, vol. 315, pp. 629–634, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Jaca, P. Govender, M. Locketz, and R. Naidoo, “The role of miRNA-21 and epithelial mesenchymal transition (EMT) process in colorectal cancer,” Journal of Clinical Pathology, vol. 70, no. 4, pp. 331–336, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Lapertosa, P. Baracchini, E. Fulcheri, and R. Tanzi, “Prognostic value of the immunocytochemical detection of extramural venous invasion in Duke's C colorectal adenocarcinomas,” The American Journal of Pathology, vol. 135, no. 5, pp. 939–945, 1989. View at Google Scholar · View at Scopus
  26. Y. Chen, H. S. Jiang, L. J. Ma, S. Q. Liu, and Z. J. Jin, “Xu Q.Clinical significance and correlation of RhoGDI2 and EMT-related proteins expression in colorectal carcinoma tissues,” Chin J Lab Diagn, pp. 1465–1469, 2015. View at Google Scholar
  27. C. Zhang, J. H. Xu, T. Liu, and H. Cui, “Clinical of signal transduction and activators of transcription 3,E-cadherin in colon cancer,” Chin J Gastrointest Surg, vol. 14, pp. 202–205, 2011. View at Google Scholar
  28. L. F. Lau, C. Murone, D. S. Williams et al., “Metabolic response evaluation for colorectal liver metastases and correlation to pathologic response and tumour markers,” ANZ Journal of Surgery, vol. 88, no. 3, pp. E108–E113, 2018. View at Publisher · View at Google Scholar
  29. L. L. Li, Expression and Clinical Significance of E-Canderin and Vimentin in Han and Uigur in Xinjiang Area of Colon Cancer, Xinjiang Medical University, 2015.
  30. Z.-H. Gao, C. Lu, Z.-N. Wang et al., “ILEI: A novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer,” Histopathology, vol. 65, no. 4, pp. 527–538, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. L.-G. Liu, X.-B. Yan, R.-T. Xie, Z.-M. Jin, and Y. Yang, “Stromal expression of vimentin predicts the clinical outcome of stage II colorectal cancer for high-risk patients,” Medical Science Monitor, vol. 23, pp. 2897–2905, 2017. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Xiao, L. Liu, X. Lu, J. Long, X. Zhou, and M. Fang, “The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin,” Journal of Cancer Research and Clinical Oncology, vol. 141, no. 8, pp. 1465–1474, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Huang, Z. Ai, N. Li et al., “Over expression of galectin-3 associates with short-term poor prognosis in stage II colon cancer,” Cancer Biomarkers, vol. 17, no. 4, pp. 445–455, 2017. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Wang, Z. Wu, and L. Hu, “Epithelial-Mesenchymal Transition Phenotype, Metformin, and Survival for Colorectal Cancer Patients with Diabetes Mellitus II,” Gastroenterology Research and Practice, vol. 2017, Article ID 2520581, 2017. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Cai and S. Xie, “Determination of emission factors from motor vehicles under different emission standards in China,” Journal of Peking University: Natural Science Edition, vol. 03, pp. 319–326, 2010. View at Google Scholar
  36. E. Choi, J. S. Bae, M. J. Kang et al., “Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance,” Oncology Reports, vol. 38, no. 3, pp. 1695–1705, 2017. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Satelli and S. Li, “Vimentin in cancer and its potential as a molecular target for cancer therapy,” Cellular and Molecular Life Sciences, vol. 68, no. 18, pp. 3033–3046, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Fuyuhiro, M. Yashiro, S. Noda et al., “Clinical significance of vimentin-positive gastric cancer cells,” Anticancer Reseach, vol. 30, no. 12, pp. 5239–5244, 2010. View at Google Scholar · View at Scopus
  39. H. Jin, S. Morohashi, F. Sato et al., “Vimentin expression of esophageal squamous cell carcinoma and its aggressive potential for lymph node metastasis,” Journal of Biomedical Research, vol. 31, no. 2, pp. 105–112, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Hu, S. H. Lau, C.-H. Tzang et al., “Association of Vimentin overexpression and hepatocellular carcinoma metastasis,” Oncogene, vol. 23, no. 1, pp. 298–302, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. L. McInroy and A. Määttä, “Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion,” Biochemical and Biophysical Research Communications, vol. 360, no. 1, pp. 109–114, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Bukhari, T. A. Mokhdomi, N. A. Chikan et al., “Affinity proteomics led identification of vimentin as a potential biomarker in colon cancers: Insights from serological screening and computational modelling,” Molecular BioSystems, vol. 11, no. 1, pp. 159–169, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Nakashima, S.-X. Jiang, Y. Sato et al., “Prevalent and up-regulated vimentin expression in micropapillary components of lung adenocarcinomas and its adverse prognostic significance,” Pathology International, vol. 65, no. 4, pp. 183–192, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. W. Tian, G. Wang, J. Yang, Y. Pan, and Y. Ma, “Prognostic role of E-cadherin and Vimentin expression in various subtypes of soft tissue leiomyosarcomas,” Medical Oncology, vol. 30, no. 1, article no. 401, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. W. Saentaweesuk, N. Araki, K. Vaeteewoottacharn et al., “Activation of Vimentin is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells,” Oncology Research : Featuring Preclinical and Clinical Cancer Therapeutics, vol. 25, 2017. View at Publisher · View at Google Scholar
  46. Z. Ye, X. Zhang, Y. Luo et al., “Prognostic values of vimentin expression and its clinicopathological significance in non-small cell lung cancer: A meta-analysis of observational studies with 4118 cases,” PLoS ONE, vol. 11, no. 9, Article ID e0163162, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Yoshikawa, Y. Morine, T. Ikemoto et al., “Elevated preoperative serum cea level is associated with poor prognosis in patients with hepatocellular carcinoma through the epithelial-mesenchymal transition,” Anticancer Reseach, vol. 37, no. 3, pp. 1169–1175, 2017. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Wang, P. Guo, Z. Zhu et al., “Pleomorphic adenoma gene like-2 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human colorectal adenocarcinoma,” Oncology Reports, vol. 37, no. 4, pp. 1961–1970, 2017. View at Publisher · View at Google Scholar
  49. K. Ye, Q. Chen, Y. Sun, J. Lin, and J. Xu, “Loss of BMI-1 dampens migration and EMT of colorectal cancer in inflammatory microenvironment through TLR4/MD-2/MyD88-mediated NF-κB signaling,” Journal of Cellular Biochemistry, vol. 119, no. 2, pp. 1922–1930, 2018. View at Publisher · View at Google Scholar
  50. H.-K. Cai, X. Chen, Y.-H. Tang, and Y.-C. Deng, “MicroRNA-194 modulates epithelial–mesenchymal transition in human colorectal cancer metastasis,” OncoTargets and Therapy, vol. 10, pp. 1269–1278, 2017. View at Publisher · View at Google Scholar · View at Scopus
  51. F. Cui, S. Wang, I. Lao et al., “miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes,” Oncology Reports, vol. 36, no. 1, pp. 487–493, 2016. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Kong, W. Sun, C. Li et al., “Long non-coding RNA LINC01133 inhibits epithelial–mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6,” Cancer Letters, vol. 380, no. 2, pp. 476–484, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Nguyen, E. I. Ager, J. Neo, and C. Christophi, “Regulation of colorectal cancer cell epithelial to mesenchymal transition by the renin angiotensin system,” Journal of Gastroenterology and Hepatology, vol. 31, no. 10, pp. 1773–1782, 2016. View at Publisher · View at Google Scholar · View at Scopus
  54. G. Lahat, Q.-S. Zhu, K.-L. Huang et al., “Vimentin is a novel anti-cancer therapeutic target; insights from In Vitro and In Vivo mice xenograft studies,” PLoS ONE, vol. 5, no. 4, Article ID e10105, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. A. V. Hugwil, “The meaning of the anti-cancer antibody CLN-IgG (Pritumumab) generated by human×human hybridoma technology against the cyto-skeletal protein, vimentin, in the course of the treatment of malignancy,” Medical Hypotheses, vol. 81, no. 3, pp. 489–495, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. S. K. Fung, T. Zou, B. Cao et al., “Cyclometalated Gold(III) Complexes Containing N-Heterocyclic Carbene Ligands Engage Multiple Anti-Cancer Molecular Targets,” Angewandte Chemie International Edition, vol. 56, no. 14, pp. 3892–3896, 2017. View at Publisher · View at Google Scholar · View at Scopus
  57. Y.-J. Lai, C.-J. Tai, C.-W. Wang et al., “Anti-Cancer Activity of Solanum nigrum (AESN) through Suppression of Mitochondrial Function and Epithelial-Mesenchymal Transition (EMT) in Breast Cancer Cells,” Molecules (Basel, Switzerland), vol. 21, no. 5, 2016. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Xu, H. Yang, X. Zhou, H. Wang, L. Gong, and C. Tang, “Bisdemethoxycurcumin suppresses migration and invasion of highly metastatic 95D lung cancer cells by regulating E-cadherin and vimentin expression, and inducing autophagy,” Molecular Medicine Reports, vol. 12, no. 5, pp. 7603–7608, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. J. A. C. Sterne, D. Gavaghan, and M. Egger, “Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature,” Journal of Clinical Epidemiology, vol. 53, no. 11, pp. 1119–1129, 2000. View at Publisher · View at Google Scholar · View at Scopus